Amal El-Bakush, MD
Critical Care Medicine · Cedar Rapids, IANPI 1609162908
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (48.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 72.0% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2023 at $11,437 and has fallen 93.5% since, to $744 in 2025. Among critical care medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $67.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- AstraZeneca$1K
- Boehringer Ingelheim$709
- United Therapeutics Corporation$559
- GSK$526
- AbbVie$350
- plus $2K from 28 others
What the payments were for
- Travel & lodging$4,25423%
- Food & beverage$5,50429%
- Education$9,07148%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 34 | $13,552 |
| AstraZeneca | 47 | $1,295 |
| Boehringer Ingelheim | 37 | $709 |
| United Therapeutics Corporation | 17 | $559 |
| GSK | 39 | $526 |
| AbbVie(2 entities) | 10 | $350 |
| Regeneron Healthcare Solutions, Inc. | 11 | $212 |
| Sanofi | 10 | $198 |
| Merck | 8 | $163 |
| Grifols USA, LLC | 6 | $135 |
| Harmony Biosciences LLC | 6 | $122 |
| Mylan Specialty L.p. | 6 | $112 |
| Johnson & Johnson | 5 | $107 |
| Amgen | 7 | $104 |
| Bayer | 4 | $77 |
| Baxter Healthcare | 3 | $57 |
| La Jolla Pharmaceutical Company | 3 | $55 |
| Gilead | 2 | $50 |
| ERBE USA Inc | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $44 |
| Jazz Pharmaceuticals Inc. | 2 | $42 |
| Philips North America LLC | 2 | $35 |
| Conmed Corporation | 1 | $33 |
| Insmed, Inc. | 2 | $32 |
| Electromed, Inc. | 2 | $28 |
| Viatris Specialty LLC | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Resmed Corp | 1 | $27 |
| Shire North American Group Inc | 2 | $25 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Pfizer | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Advanced Respiratory, Inc | 1 | $15 |
| Inogen, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$13,071
- BREZTRI$128
- SYMBICORT$128
- AIRSUPRA$126
How this compares
$18,829 in reported general payments places this provider in the 95th percentile of 33 critical care medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 464 | $329,205 |
| Breo ElliptaFluticasone/Vilanterol | 279 | $116,286 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 161 | $108,599 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 187 | $97,040 |
| Dupixent SyringeDupilumab | 11 | $41,468 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 52 | $27,160 |
| SymbicortBudesonide/Formoterol Fumarate | 76 | $20,522 |
| Spiriva RespimatTiotropium Bromide | 30 | $18,400 |
| Advair HfaFluticasone Propion/Salmeterol | 35 | $14,280 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 27 | $11,200 |
| Incruse ElliptaUmeclidinium Bromide | 25 | $10,450 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 44 | $10,021 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 267 | $6,975 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 65 | $5,945 |
| Arnuity ElliptaFluticasone Furoate | 20 | $5,105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $526 | $558,086975 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,295 | $140,321264 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $709 | $45,56182 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 33 critical care medicine providers in Iowa.
Other critical care medicine in Cedar Rapids
- Katherine KavanaughCedar Rapids$2K
- Andrei SchwartzCedar Rapids$1K
- Humphrey WongDavenport$31K
- Lovkesh AroraIowa City$5K
- Charles RappaportIowa City$4K
- David KaczkaIowa City$4K
- Amith George JacobIowa City$3K
- Gregory SchmidtIowa City$2K
- Swaroopa Rani NalamalapuWaterloo$2K
- Iaswarya GanapathirajuDes Moines$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.